Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab

BACKGROUND: A number of clinical studies focused on treating a single food allergy through oral immunotherapy (OIT) with adjunctive omalizumab treatment have been published. We previously demonstrated safety and tolerability of a rapid OIT protocol using omalizumab in a phase 1 study to achieve dese...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Allergy Asthma Clin Immunol
Glavni autori: Andorf, Sandra, Manohar, Monali, Dominguez, Tina, Block, Whitney, Tupa, Dana, Kshirsagar, Rohun A., Sampath, Vanitha, Chinthrajah, R. Sharon, Nadeau, Kari C.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5738812/
https://ncbi.nlm.nih.gov/pubmed/29296107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13223-017-0223-8
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items